Barriers affecting COVID‑19 vaccination in Phalombe District, Malawi: A qualitative study

Background. In Malawi, only 1 072 229 people out of a national target population of 13 546 324 had received at least one dose of the AstraZeneca COVID‑19 vaccine by 26 December 2021, and only 672 819 people were classified as fully vaccinated. Phalombe District in Malawi had particularly low COVID‑19 vaccine uptake, with only 4% (n=8 538) of 225 219 people being fully vaccinated by 26 December. Objectives. To explore reasons for vaccine hesitancy and refusal among people living in Phalombe District. Methods. This cross-sectional qualitative study employed six focus group discussions (FGDs) and 19 in-depth interviews (IDIs) to collect data. We purposefully selected two traditional authorities (TAs), Nazombe and Nkhumba, as study areas, and conducted FGDs and IDIs in 6 randomly selected villages in these two TAs. Participants were religious leaders, traditional leaders, youths, traditional healers and ordinary community members. We explored reasons for vaccine refusal and hesitancy, how contextual cultural beliefs influenced people’s decision to receive the COVID‑19 vaccine, and which sources of information were trusted in the community. Data were analysed using thematic content analysis. Results. We conducted 19 IDIs and six FGDs. Themes that emerged from the data were reasons for vaccine refusal and hesitancy, contextual cultural beliefs affecting the decision whether to be vaccinated, ways to improve COVID‑19 vaccine uptake, and means of communicating information about COVID‑19 vaccines. Participants mentioned that myths contributing to vaccine refusal and hesitancy circulated in the community through social media. With regard to contextual cultural beliefs, most participants believed that COVID‑19 was a disease of rich people, while others believed that it signalled the end of the world and that it could not be cured. Conclusion. Health systems should recognise and acknowledge the reasons leading to vaccine hesitancy and refusal and address these appropriately to improve vaccine uptake. Effective community sensitisation and engagement should be enhanced to clarify myths and address misinformation about the COVID‑19 vaccine

Synthesis and photo electrochemical characterization of an extended π-conjugated heteroleptic ruthenium (II) complex

A new extended π-conjugate heteroleptic ruthenium(II) complex (m-HRD-1) that contains a 4,4'-bis-2-(5(3,5-di-tert-butylphenyl)thiophene-2-yl)vinyl)2,2'-bipyridine as ancillary ligand, 4,4’-dicaboxy-2,2'-bipyridine as anchoring group, and two thiocyanate ligands in its molecular structure have been designed, synthesized and characterized by CHN, Mass, 1H-NMR, UV-Vis, and fluorescence spectroscopies as well as cyclic voltammetry. Electrochemical and theoretical studies showed that the LUMO of the sensitizer is above TiO2 conduction band and the HOMO is below the redox potential of the electrolyte. This new sensitizer was tested in dye-sensitized solar cells using liquid redox couple (I-/I3-) and its performance was compared to the standard sensitizer N719

Effect of sub-optimal moisture levels on the quality of groundnut (Arachis hypogaea L.) during storage in triple-layer hermetic storage bags

Storage is an important aspect of groundnut, as the in-shell and shelled kernels are prone to infestation by insects, pests, and fungi. Among several storage pests, the groundnut bruchid, Caryedon serratus, causes serious losses. Farmers often resort to different management practices, including hermetic storage, to control it. The moisture content of the commodity plays an important role in insect infestation during storage. Drying to safe moisture levels before storage is known to prevent the activity of various living organisms, such as storage pests. However, drying to low levels of moisture may not be economical for farmers, as they may not have access to devices to accurately check product moisture. In this regard, we wanted to demonstrate the efficacy of triple-layer hermetic storage bags in preventing the damage caused by C. serratus when the groundnuts are stored at intermediate (10%) and high (14%) levels of moisture compared to traditionally used bags such as polypropylene bags and jute bags. Groundnut pods at 10% moisture content and 14% moisture content were separately inoculated with adult bruchids and a toxigenic strain of Aspergillus flavus fungal inoculum before storing them for 6 months. Results from groundnut samples taken at two-month intervals indicated that groundnut pods stored in triple-layer hermetic bags were completely free from infestation by C. serratus by recording a zero number of eggs laid, number of pupae, adult emergence, percentage of loss, and percentage of damage up to 6 months of storage, by creating low oxygen (hypoxia) and high carbon dioxide (hypercarbia) conditions. Results also indicate no loss of pod weight stored in triple-layer bags, but a slight reduction in germination percentage was recorded due to a slight increase in fungal activity, but the reduction was significantly less in triple-layer plastic bags compared to other bag types. Similarly, biochemical constituents such as oil and protein content were slightly reduced in triple-layer plastic bags when pods were stored at a 10% moisture level, but a higher reduction was observed at a 14% moisture level. However, the reduction was very high and significant in other bag types at both 10 and 14% moisture levels

Effect of sub-optimal moisture levels on the quality of groundnut (Arachis hypogaea L.) during storage in triple-layer hermetic storage bags

Storage is an important aspect of groundnut, as the in-shell and shelled kernels are prone to infestation by insects, pests, and fungi. Among several storage pests, the groundnut bruchid, Caryedon serratus, causes serious losses. Farmers often resort to different management practices, including hermetic storage, to control it. The moisture content of the commodity plays an important role in insect infestation during storage. Drying to safe moisture levels before storage is known to prevent the activity of various living organisms, such as storage pests. However, drying to low levels of moisture may not be economical for farmers, as they may not have access to devices to accurately check product moisture. In this regard, we wanted to demonstrate the efficacy of triple-layer hermetic storage bags in preventing the damage caused by C. serratus when the groundnuts are stored at intermediate (10%) and high (14%) levels of moisture compared to traditionally used bags such as polypropylene bags and jute bags. Groundnut pods at 10% moisture content and 14% moisture content were separately inoculated with adult bruchids and a toxigenic strain of Aspergillus flavus fungal inoculum before storing them for 6 months. Results from groundnut samples taken at two-month intervals indicated that groundnut pods stored in triple-layer hermetic bags were completely free from infestation by C. serratus by recording a zero number of eggs laid, number of pupae, adult emergence, percentage of loss, and percentage of damage up to 6 months of storage, by creating low oxygen (hypoxia) and high carbon dioxide (hypercarbia) conditions. Results also indicate no loss of pod weight stored in triple-layer bags, but a slight reduction in germination percentage was recorded due to a slight increase in fungal activity, but the reduction was significantly less in triple-layer plastic bags compared to other bag types. Similarly, biochemical constituents such as oil and protein content were slightly reduced in triple-layer plastic bags when pods were stored at a 10% moisture level, but a higher reduction was observed at a 14% moisture level. However, the reduction was very high and significant in other bag types at both 10 and 14% moisture levels

Crocins with high levels of sugar conjugation contribute to the yellow colours of early-spring flowering

Crocus sativus is the source of saffron spice, the processed stigma which accumulates glucosylated apocarotenoids known as crocins. Crocins are found in the stigmas of other Crocuses, determining the colourations observed from pale yellow to dark red. By contrast, tepals in Crocus species display a wider diversity of colours which range from purple, blue, yellow to white. In this study, we investigated whether the contribution of crocins to colour extends from stigmas to the tepals of yellow Crocus species. Tepals from seven species were analysed by UPLC-PDA and ESI-Q-TOF-MS/MS revealing for the first time the presence of highly glucosylated crocins in this tissue. beta-carotene was found to be the precursor of these crocins and some of them were found to contain rhamnose, never before reported. When crocin profiles from tepals were compared with those from stigmas, clear differences were found, including the presence of new apocarotenoids in stigmas. Furthermore, each species showed a characteristic profile which was not correlated with the phylogenetic relationship among species. While gene expression analysis in tepals of genes involved in carotenoid metabolism showed that phytoene synthase was a key enzyme in apocarotenoid biosynthesis in tepals. Expression of a crocetin glucosyltransferase, previously identified in saffron, was detected in all the samples. The presence of crocins in tepals is compatible with the role of chromophores to attract pollinators. The identification of tepals as new sources of crocins is of special interest given their wide range of applications in medicine, cosmetics and colouring industries.The laboratory is supported by the Spanish Ministerio de Ciencia e Innovacion (BIO2009-07803) and participates in the IBERCAROT network (112RT0445). Dr. Ahrazem was funded by FPCYTA through the INCRECYT Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Rubio-Moraga, A.; Ahrazem, O.; Rambla Nebot, JL.; Granell Richart, A.; Gómez Gómez, L. (2013). Crocins with high levels of sugar conjugation contribute to the yellow colours of early-spring flowering. PLoS ONE. 8(9):71946-71946. https://doi.org/10.1371/journal.pone.0071946S719467194689Auldridge, M. E., McCarty, D. R., & Klee, H. J. (2006). Plant carotenoid cleavage oxygenases and their apocarotenoid products. Current Opinion in Plant Biology, 9(3), 315-321. doi:10.1016/j.pbi.2006.03.005AKIYAMA, K. (2007). Chemical Identification and Functional Analysis of Apocarotenoids Involved in the Development of Arbuscular Mycorrhizal Symbiosis. Bioscience, Biotechnology, and Biochemistry, 71(6), 1405-1414. doi:10.1271/bbb.70023Lendzemo, V. W., Kuyper, T. W., Matusova, R., Bouwmeester, H. J., & Ast, A. V. (2007). Colonization by Arbuscular Mycorrhizal Fungi of Sorghum Leads to Reduced Germination and Subsequent Attachment and Emergence ofStriga hermonthica. Plant Signaling & Behavior, 2(1), 58-62. doi:10.4161/psb.2.1.3884Gomez-Roldan, V., Fermas, S., Brewer, P. B., Puech-Pagès, V., Dun, E. A., Pillot, J.-P., … Rochange, S. F. (2008). Strigolactone inhibition of shoot branching. Nature, 455(7210), 189-194. doi:10.1038/nature07271Umehara, M., Hanada, A., Yoshida, S., Akiyama, K., Arite, T., Takeda-Kamiya, N., … Yamaguchi, S. (2008). Inhibition of shoot branching by new terpenoid plant hormones. Nature, 455(7210), 195-200. doi:10.1038/nature07272Jella, P., Rouseff, R., Goodner, K., & Widmer, W. (1998). Determination of Key Flavor Components in Methylene Chloride Extracts from Processed Grapefruit Juice. Journal of Agricultural and Food Chemistry, 46(1), 242-247. doi:10.1021/jf9702149Pfander, H., & Schurtenberger, H. (1982). Biosynthesis of C20-carotenoids in Crocus sativus. Phytochemistry, 21(5), 1039-1042. doi:10.1016/s0031-9422(00)82412-7Bathaie, S. Z., & Mousavi, S. Z. (2010). New Applications and Mechanisms of Action of Saffron and its Important Ingredients. Critical Reviews in Food Science and Nutrition, 50(8), 761-786. doi:10.1080/10408390902773003Abdullaev, F. I., & Espinosa-Aguirre, J. J. (2004). Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detection and Prevention, 28(6), 426-432. doi:10.1016/j.cdp.2004.09.002Zhang Z, Wang CZ, Wen XD, Shoyama Y, Yuan CS (2013) Role of saffron and its constituents on cancer chemoprevention. Pharm Biol.Schmidt, M., Betti, G., & Hensel, A. (2007). Saffron in phytotherapy: Pharmacology and clinical uses. Wiener Medizinische Wochenschrift, 157(13-14), 315-319. doi:10.1007/s10354-007-0428-4Howes, M.-J. R., & Perry, E. (2011). The Role of Phytochemicals in the Treatment and Prevention of Dementia. Drugs & Aging, 28(6), 439-468. doi:10.2165/11591310-000000000-00000Castillo, R., Fernández, J.-A., & Gómez-Gómez, L. (2005). Implications of Carotenoid Biosynthetic Genes in Apocarotenoid Formation during the Stigma Development of Crocus sativus and Its Closer Relatives. Plant Physiology, 139(2), 674-689. doi:10.1104/pp.105.067827Moraga, Á. R., Rambla, J. L., Ahrazem, O., Granell, A., & Gómez-Gómez, L. (2009). Metabolite and target transcript analyses during Crocus sativus stigma development. Phytochemistry, 70(8), 1009-1016. doi:10.1016/j.phytochem.2009.04.022Rubio-Moraga, A., Trapero, A., Ahrazem, O., & Gómez-Gómez, L. (2010). Crocins transport in Crocus sativus: The long road from a senescent stigma to a newborn corm. Phytochemistry, 71(13), 1506-1513. doi:10.1016/j.phytochem.2010.05.026Moraga, A. R., Nohales, P. F., P�rez, J. A. F., & G�mez-G�mez, L. (2004). Glucosylation of the saffron apocarotenoid crocetin by a glucosyltransferase isolated from Crocus sativus stigmas. Planta, 219(6), 955-966. doi:10.1007/s00425-004-1299-1Harpke, D., Meng, S., Rutten, T., Kerndorff, H., & Blattner, F. R. (2013). Phylogeny of Crocus (Iridaceae) based on one chloroplast and two nuclear loci: Ancient hybridization and chromosome number evolution. Molecular Phylogenetics and Evolution, 66(3), 617-627. doi:10.1016/j.ympev.2012.10.007Mathew B (1982) The crocus - A revision of the Genus crocus; Batsford B, editor. London.Nørbæk, R., Nielsen, K., & Kondo, T. (2002). Anthocyanins from flowers of Cichorium intybus. Phytochemistry, 60(4), 357-359. doi:10.1016/s0031-9422(02)00055-9Zhu, C., Bai, C., Sanahuja, G., Yuan, D., Farré, G., Naqvi, S., … Christou, P. (2010). The regulation of carotenoid pigmentation in flowers. Archives of Biochemistry and Biophysics, 504(1), 132-141. doi:10.1016/j.abb.2010.07.028OHMIYA, A. (2011). Diversity of Carotenoid Composition in Flower Petals. Japan Agricultural Research Quarterly: JARQ, 45(2), 163-171. doi:10.6090/jarq.45.163KISHIMOTO, S., MAOKA, T., SUMITOMO, K., & OHMIYA, A. (2005). Analysis of Carotenoid Composition in Petals of Calendula (Calendula officinalisL.). Bioscience, Biotechnology, and Biochemistry, 69(11), 2122-2128. doi:10.1271/bbb.69.2122Ohmiya, A., Kishimoto, S., Aida, R., Yoshioka, S., & Sumitomo, K. (2006). Carotenoid Cleavage Dioxygenase (CmCCD4a) Contributes to White Color Formation in Chrysanthemum Petals. Plant Physiology, 142(3), 1193-1201. doi:10.1104/pp.106.087130Ohmiya, A., Sumitomo, K., & Aida, R. (2009). «Yellow Jimba»: Suppression of Carotenoid Cleavage Dioxygenase (CmCCD4a) Expression Turns White Chrysanthemum Petals Yellow. Journal of the Japanese Society for Horticultural Science, 78(4), 450-455. doi:10.2503/jjshs1.78.450Brandi, F., Bar, E., Mourgues, F., Horváth, G., Turcsi, E., Giuliano, G., … Rosati, C. (2011). Study of «Redhaven» peach and its white-fleshed mutant suggests a key role of CCD4 carotenoid dioxygenase in carotenoid and norisoprenoid volatile metabolism. BMC Plant Biology, 11(1), 24. doi:10.1186/1471-2229-11-24Campbell, R., Ducreux, L. J. M., Morris, W. L., Morris, J. A., Suttle, J. C., Ramsay, G., … Taylor, M. A. (2010). The Metabolic and Developmental Roles of Carotenoid Cleavage Dioxygenase4 from Potato. Plant Physiology, 154(2), 656-664. doi:10.1104/pp.110.158733Ahrazem, O., Rubio-Moraga, A., Lopez, R. C., & Gomez-Gomez, L. (2009). The expression of a chromoplast-specific lycopene beta cyclase gene is involved in the high production of saffron’s apocarotenoid precursors. Journal of Experimental Botany, 61(1), 105-119. doi:10.1093/jxb/erp283Ahrazem, O., Rubio-Moraga, A., Trapero, A., & Gomez-Gomez, L. (2011). Developmental and stress regulation of gene expression for a 9-cis-epoxycarotenoid dioxygenase, CstNCED, isolated from Crocus sativus stigmas. Journal of Experimental Botany, 63(2), 681-694. doi:10.1093/jxb/err293Moraga, Á., Mozos, A., Ahrazem, O., & Gómez-Gómez, L. (2009). Cloning and characterization of a glucosyltransferase from Crocus sativus stigmas involved in flavonoid glucosylation. BMC Plant Biology, 9(1), 109. doi:10.1186/1471-2229-9-109Tarantilis, P. A., Tsoupras, G., & Polissiou, M. (1995). Determination of saffron (Crocus sativus L.) components in crude plant extract using high-performance liquid chromatography-UV-visible photodiode-array detection-mass spectrometry. Journal of Chromatography A, 699(1-2), 107-118. doi:10.1016/0021-9673(95)00044-nWalter, M. H., Fester, T., & Strack, D. (2000). Arbuscular mycorrhizal fungi induce the non-mevalonate methylerythritol phosphate pathway of isoprenoid biosynthesis correlated with accumulation of the «yellow pigment» and other apocarotenoids. The Plant Journal, 21(6), 571-578. doi:10.1046/j.1365-313x.2000.00708.xGómez-Miranda, B., Rupérez, P., & Leal, J. A. (1981). Changes in chemical composition during germination ofbotrytis cinerea sclerotia. Current Microbiology, 6(4), 243-246. doi:10.1007/bf01566981Cooper, C. M., Davies, N. W., & Menary, R. C. (2003). C-27 Apocarotenoids in the Flowers ofBoronia megastigma(Nees). Journal of Agricultural and Food Chemistry, 51(8), 2384-2389. doi:10.1021/jf026007cFloss, D. S., Schliemann, W., Schmidt, J., Strack, D., & Walter, M. H. (2008). RNA Interference-Mediated Repression of MtCCD1 in Mycorrhizal Roots of Medicago truncatula Causes Accumulation of C27 Apocarotenoids, Shedding Light on the Functional Role of CCD1. Plant Physiology, 148(3), 1267-1282. doi:10.1104/pp.108.125062Fester, T., Schmidt, D., Lohse, S., Walter, M., Giuliano, G., Bramley, P., … Strack, D. (2002). Stimulation of carotenoid metabolism in arbuscular mycorrhizal roots. Planta, 216(1), 148-154. doi:10.1007/s00425-002-0917-zKlingner, A., Bothe, H., Wray, V., & Marner, F.-J. (1995). Identification of a yellow pigment formed in maize roots upon mycorrhizal colonization. Phytochemistry, 38(1), 53-55. doi:10.1016/0031-9422(94)00538-5Rychener, M., Bigler, P., & Pfander, H. (1984). Isolierung und Strukturaufkl�rung von Neapolitanose (O-?-D-Glucopyranosyl-(1?2)-O-[?-D-glucopyranosyl-(1?6)]-(D-glucose), einem neuen Trisaccharid aus den Stempeln von Gartenkrokussen (Crocus neapolitanus var.). Helvetica Chimica Acta, 67(2), 386-391. doi:10.1002/hlca.19840670205Lu, S., Van Eck, J., Zhou, X., Lopez, A. B., O’Halloran, D. M., Cosman, K. M., … Li, L. (2006). The Cauliflower Or Gene Encodes a DnaJ Cysteine-Rich Domain-Containing Protein That Mediates High Levels of β-Carotene Accumulation. The Plant Cell, 18(12), 3594-3605. doi:10.1105/tpc.106.046417Rubio, A., Rambla, J. L., Santaella, M., Gómez, M. D., Orzaez, D., Granell, A., & Gómez-Gómez, L. (2008). Cytosolic and Plastoglobule-targeted Carotenoid Dioxygenases fromCrocus sativusAre Both Involved in β-Ionone Release. Journal of Biological Chemistry, 283(36), 24816-24825. doi:10.1074/jbc.m804000200Dufresne, C., Cormier, F., & Dorion, S. (1997). In VitroFormation of Crocetin Glucosyl Esters byCrocus sativusCallus Extract. Planta Medica, 63(02), 150-153. doi:10.1055/s-2006-957633Wakelin, A. M., Lister, C. E., & Conner, A. J. (2003). Inheritance and Biochemistry of Pollen Pigmentation in California Poppy (Eschscholzia californica Cham.). International Journal of Plant Sciences, 164(6), 867-875. doi:10.1086/378825Cooper, C. M., Davies, N. W., & Menary, R. C. (2009). Changes in Some Carotenoids and Apocarotenoids during Flower Development in Boronia megastigma (Nees). Journal of Agricultural and Food Chemistry, 57(4), 1513-1520. doi:10.1021/jf802610pPfister, S., Meyer, P., Steck, A., & Pfander, H. (1996). Isolation and Structure Elucidation of Carotenoid−Glycosyl Esters in Gardenia Fruits (Gardenia jasminoidesEllis) and Saffron (CrocussativusLinne). Journal of Agricultural and Food Chemistry, 44(9), 2612-2615. doi:10.1021/jf950713eDufresne, C., Cormier, F., Dorion, S., Niggli, U. A., Pfister, S., & Pfander, H. (1999). Glycosylation of encapsulated crocetin by a Crocus sativus L. cell culture. Enzyme and Microbial Technology, 24(8-9), 453-462. doi:10.1016/s0141-0229(98)00143-4Lundmark, M., Hurry, V., & Lapointe, L. (2009). Low temperature maximizes growth of Crocus vernus (L.) Hill via changes in carbon partitioning and corm development. Journal of Experimental Botany, 60(7), 2203-2213. doi:10.1093/jxb/erp103Schliemann, W., Schmidt, J., Nimtz, M., Wray, V., Fester, T., & Strack, D. (2006). Accumulation of apocarotenoids in mycorrhizal roots of Ornithogalum umbellatum. Phytochemistry, 67(12), 1196-1205. doi:10.1016/j.phytochem.2006.05.005Gómez-Gómez L, Moraga-Rubio A, Ahrazem O (2010) Understanding Carotenoid Metabolism in Saffron Stigmas: Unravelling Aroma and Colour Formation. In: Teixeira da Silva JA, editor. Functional Plant Science adn Biotechnology United Kingdon: GLOBAL SCIENCE BOOKS. pp.56–63.Schwartz, S. H., Qin, X., & Zeevaart, J. A. D. (2001). Characterization of a Novel Carotenoid Cleavage Dioxygenase from Plants. Journal of Biological Chemistry, 276(27), 25208-25211. doi:10.1074/jbc.m102146200Ilg, A., Yu, Q., Schaub, P., Beyer, P., & Al-Babili, S. (2010). Overexpression of the rice carotenoid cleavage dioxygenase 1 gene in Golden Rice endosperm suggests apocarotenoids as substrates in planta. Planta, 232(3), 691-699. doi:10.1007/s00425-010-1205-yAlmeida, E. R. A., & Cerdá-Olmedo, E. (2008). Gene expression in the regulation of carotene biosynthesis in Phycomyces. Current Genetics, 53(3), 129-137. doi:10.1007/s00294-007-0170-xKachanovsky, D. E., Filler, S., Isaacson, T., & Hirschberg, J. (2012). Epistasis in tomato color mutations involves regulation of phytoene synthase 1 expression by cis-carotenoids. Proceedings of the National Academy of Sciences, 109(46), 19021-19026. doi:10.1073/pnas.1214808109Walter, M. H., Floss, D. S., & Strack, D. (2010). Apocarotenoids: hormones, mycorrhizal metabolites and aroma volatiles. Planta, 232(1), 1-17. doi:10.1007/s00425-010-1156-3GIACCIO, M. (2004). Crocetin from Saffron: An Active Component of an Ancient Spice. Critical Reviews in Food Science and Nutrition, 44(3), 155-172. doi:10.1080/10408690490441433Hosseinzadeh, H., & Nassiri-Asl, M. (2012). Avicenna’s (Ibn Sina) the Canon of Medicine and Saffron (Crocus sativus): A Review. Phytotherapy Research, 27(4), 475-483. doi:10.1002/ptr.4784Ochiai, T., Shimeno, H., Mishima, K., Iwasaki, K., Fujiwara, M., Tanaka, H., … Soeda, S. (2007). Protective effects of carotenoids from saffron on neuronal injury in vitro and in vivo. Biochimica et Biophysica Acta (BBA) - General Subjects, 1770(4), 578-584. doi:10.1016/j.bbagen.2006.11.01

EPMA-World Congress 2015: Bonn, Germany. 3-5 September 2015

Table of contents A1 Predictive and prognostic biomarker panel for targeted application of radioembolisation improving individual outcomes in hepatocellular carcinoma Jella-Andrea Abraham, Olga Golubnitschaja A2 Integrated market access approach amplifying value of “Rx-CDx” Ildar Akhmetov A3 Disaster response: an opportunity to improve global healthcare Russell J. Andrews, Leonidas Quintana A4 USA PPPM: proscriptive, profligate, profiteering medicine-good for 1 % wealthy, not for 99 % unhealthy Russell J. Andrews A5 The role of IDO in a murine model of gingivitis: predictive and therapeutic potentials Babak Baban, Jun Yao Liu, Xu Qin, Tailing Wang, Mahmood S. Mozaffari A6 Specific diets for personalised treatment of diabetes type 2 Viktoriia V. Bati, Tamara V. Meleshko, Olga B. Levchuk, Nadiya V. Boyko A7 Towards personalized physiotherapeutic approach Joanna Bauer, Ewa Boerner, Halina Podbielska A8 Cells, animal, SHIME and in silico models for detection and verification of specific biomarkers of non-communicable chronic diseases Alojz Bomba, Viktor O. Petrov, Volodymyr G. Drobnych, Rostyslav V. Bubnov, Oksana M. Bykova, Nadiya V. Boyko A9 INTERACT-chronic care model: Self-treatment by patients with decision support e-Health solution Hans-Peter Brunner-La Rocca, Lutz Fleischhacker, Olga Golubnitschaja, Frank Heemskerk, Thomas Helms, Tiny Jaarsma, Judita Kinkorova, Jan Ramaekers, Peter Ruff, Ivana Schnur, Emilio Vanoli, Jose Verdu A10 PPPM in cardiovascular medicine in 2015 Hans-Peter Brunner-La Rocca A11 Magnetic resonance imaging of nanoparticles in mice, potential for theranostic and contrast media development – pilot results Rostyslav V. Bubnov, Sergiy A. Grabovetskyi, Olena M. Mykhalchenko, Natalia O. Tymoshok, Oleksandr B. Shcherbakov, Igor P. Semeniv, Mykola Y. Spivak A12 Ultrasound diagnosis for diabetic neuropathy - comparative study Rostyslav V. Bubnov, Tetyana V. Ostapenko A13 Ultrasound for stratification patients with diabetic foot ulcers for prevention and personalized treatment - pilot results Rostyslav V. Bubnov, Nazarii M. Kobyliak, Nadiya M. Zholobak, Mykola Ya. Spivak A14 Project ImaGenX – designing and executing a questionnaire on environment and lifestyle risk of breast cancer John Paul Cauchi A15 Genomics – a new structural brand of predictive, preventive and personalized medicine or the new driver as well? Dmitrii Cherepakhin, Marina Bakay, Artem Borovikov, Sergey Suchkov A16 Survey of questionnaires for evaluation of the quality of life in various medical fields Barbara Cieślik, Agnieszka Migasiewicz, Maria-Luiza Podbielska, Markus Pelleter, Agnieszka Giemza, Halina Podbielska A17 Personalized molecular treatment for muscular dystrophies Sebahattin Cirak A18 Secondary mutations in circulating tumour DNA for acquired drug resistance in patients with advanced ALK + NSCLC Marzia Del Re, Paola Bordi, Valentina Citi, Marta Palombi, Carmine Pinto, Marcello Tiseo, Romano Danesi A19 Recombinant species-specific FcεRI alpha proteins for diagnosis of IgE-mediated allergies in dogs, cats and horses Lukas Einhorn, Judit Fazekas, Martina Muhr, Alexandra Schoos, Lucia Panakova, Ina Herrmann, Krisztina Manzano-Szalai, Kumiko Oida, Edda Fiebiger, Josef Singer, Erika Jensen-Jarolim A20 Global methodology for developmental neurotoxicity testing in humans and animals early and chronically exposed to chemical contaminants Arpiné A. Elnar, Nadia Ouamara, Nadiya Boyko, Xavier Coumoul, Jean-Philippe Antignac, Bruno Le Bizec, Gauthier Eppe, Jenny Renaut, Torsten Bonn, Cédric Guignard, Margherita Ferrante, Maria Liusa Chiusano, Salvatore Cuzzocrea, Gerard O'Keeffe, John Cryan, Michelle Bisson, Amina Barakat, Ihsane Hmamouchi, Nasser Zawia, Anumantha Kanthasamy, Glen E. Kisby, Rui Alves, Oscar Villacañas Pérez, Kim Burgard, Peter Spencer, Norbert Bomba, Martin Haranta, Nina Zaitseva, Irina May, Stéphanie Grojean, Mathilde Body-Malapel, Florencia Harari, Raul Harari, Kristina Yeghiazaryan, Olga Golubnitschaja, Vittorio Calabrese, Christophe Nemos, Rachid Soulimani A21 Mental indicators at young people with attributes hypertension and pre-hypertension Maria E. Evsevyeva, Elena A. Mishenko, Zurida V. Kumukova, Evgeniy V. Chudnovsky, Tatyana A. Smirnova A22 On the approaches to the early diagnosis of stress-induced hypertension in young employees of State law enforcement agencies Maria E. Evsevyeva, Ludmila V. Ivanova, Michail V. Eremin, Maria V. Rostovtseva A23 Сentral aortic pressure and indexes of augmentation in young persons in view of risk factors Maria E. Evsevyeva, Michail V. Eremin, Vladimir I. Koshel, Oksana V. Sergeeva, Nadesgda M. Konovalova A24 Breast cancer prediction and prevention: Are reliable biomarkers in horizon? Shantanu Girotra, Olga Golubnitschaja A25 Flammer Syndrome and potential formation of pre-metastatic niches: A multi-centred study on phenotyping, patient stratification, prediction and potential prevention of aggressive breast cancer and metastatic disease Olga Golubnitschaja, Manuel Debald, Walther Kuhn, Kristina Yeghiazaryan, Rostyslav V. Bubnov, Vadym M. Goncharenko, Ulyana Lushchyk, Godfrey Grech, Katarzyna Konieczka A26 Innovative tools for prenatal diagnostics and monitoring: improving individual pregnancy outcomes and health-economy in EU Olga Golubnitschaja, Jan Jaap Erwich, Vincenzo Costigliola, Kristina Yeghiazaryan, Ulrich Gembruch A27 Immunohistochemical assessment of APUD cells in endometriosis Vadym M. Goncharenko, Vasyl O. Beniuk, Olga V. Kalenska, Rostyslav V. Bubnov A28 Updating personalized management algorithm of endometrial hyperplasia in pre-menopause women Vadym M. Goncharenko, Vasyl O. Beniuk, Rostyslav V. Bubnov, Olga Melnychuk A29 The personified treatment approach of polimorbid patients with periodontal inflammatory diseases Irina A. Gorbacheva, Lyudmila Y. Orekhova, Vadim V. Tachalov A30 Ukrainian experience in hybrid war – the challenge to update algorithms for personalized care and early prevention of different military injuries Olena I. Grechanyk, Rizvan Ya. Abdullaiev, Rostyslav V. Bubnov A31 Tear fluid biomarkers: a comparison of tear fluid sampling and storage protocols Suzanne Hagan, Eilidh Martin, Ian Pearce, Katherine Oliver A32 The correlation of dietary habits with gingival problems during menstruation Cenk Haytac, Fariz Salimov, Servin Yoksul, Anatoly A. Kunin, Natalia S. Moiseeva A33 Genomic medicine in a contemporary Spanish population of prostate cancer: our experience Bernardo Herrera-Imbroda, Sergio del Río-González, Maria Fernanda Lara, Antonia Angulo, Francisco Javier Machuca Santa-Cruz A34 Challenges, opportunities and collaborations for personalized medicine applicability in uro-oncological disease Bernardo Herrera-Imbroda, Sergio del Río-González, Maria Fernanda Lara A35 Metabolic hallmarks of cancer as targets for a personalized therapy John Ionescu A36 Influence of genetic polymorphism as a predictor of the development of periodontal disease in patients with gastric ulcer and 12 duodenal ulcer Alfiya Z. Isamulaeva, Anatoly A. Kunin, Shamil Sh. Magomedov, Aida I. Isamulaeva A37 Challenges in diabetic macular edema Tatjana Josifova A38 Overview of the EPMA strategies in laboratory medicine relevant for PPPM Marko Kapalla, Juraj Kubáň, Olga Golubnitschaja, Vincenzo Costigliola A39 EPMA initiative for effective organization of medical travel: European concepts and criteria Vincenzo Costigliola, Marko Kapalla, Juraj Kubáň, Olga Golubnitschaja A40 Design and innovation in e-textiles: implications for PPPM Anthony Kent, Tom Fisher, Tilak Dias A41 Biobank in Pilsen as a member of national node BBMRI_CZ Judita Kinkorová, Ondřej Topolčan A42 Big data in personalized medicine: hype and hope Matthias Kohl A43 The 3P approach as the platform of the European Dentistry Department (DPPPD) Anatoly A. Kunin, Natalia S. Moiseeva A44 The endometrium cytokine patterns for predictive diagnosis of proliferation severity and cancer prevention Andrii I. Kurchenko, Vasyl A. Beniuk, Vadym M. Goncharenko, Rostyslav V. Bubnov, Nadiya V. Boyko, Andriy M. Strokan A45 A monocyte-based in-vitro system for testing individual responses to the implanted material: future for personalized implant construction Julia Kzhyshkowska, Alexandru Gudima, Ksenia S. Stankevich, Victor D. Filimonov4, Harald Klüter, Evgeniya M. Mamontova, Sergei I. Tverdokhlebov A46 Prediction and prevention of adverse health effects by meteorological factors: Biomarker patterns and creation of a device for self-monitoring and integrated care Ulyana B. Lushchyk, Viktor V. Novytskyy, Igor P. Babii, Nadiya G. Lushchyk, Lyudmyla S. Riabets, Ivanna I. Legka A47 Targeting "disease signatures" towards personalized healthcare Mira Marcus-Kalish, Alexis Mitelpunkt, Tal Galili, Neta Shachar, Yoav Benjamini A48 Influence of the skin imperfection on the personal quality of life and possible tools for objective diagnosis Agnieszka Migasiewicz, Markus Pelleter, Joanna Bauer, Ewelina Dereń, Halina Podbielska A49 The new direction in caries prevention based on the ultrastructure of dental hard tissues and filling materials Natalia S. Moiseeva, Anatoly A. Kunin, Dmitry A. Kunin A50 The use of LED radiation in prevention of dental diseases Natalia S. Moiseeva, Yury A. Ippolitov, Dmitry A. Kunin, Alexei N. Morozov, Natalia V. Chirkova, Nakhid T. Aliev A51 Status of endothelial progenitor cells in diabetic nephropathy: predictive and preventive potentials Mahmood S. Mozaffari, Jun Yao Liu, Babak Baban A52 The status of glucocorticoid-induced leucine zipper protein in salivary gland in Sjögren’s syndrome: predictive and personalized treatment potentials Mahmood S. Mozaffari, Jun Yao Liu, Rafik Abdelsayed, Xing-Ming Shi, Babak Baban A53 Maximal aerobic capacity - important quality marker of health Jaroslav Novák, Milan Štork, Václav Zeman A54 The EMPOWER project: laboratory medicine and Horizon 2020 Wytze P. Oosterhuis, Elvar Theodorsson A55 Personality profile manifestations in patient’s attitude to oral care and adherence to doctor’s prescriptions Lyudmila Y. Orekhova, Tatyana V. Kudryavtseva, Elena R. Isaeva, Vadim V. Tachalov, Ekaterina S. Loboda A56 Results of an European survey on personalized medicine addressed to directions of laboratory medicine Mario Pazzagli, Francesca Malentacchi, Irene Mancini, Ivan Brandslund, Pieter Vermeersch, Matthias Schwab, Janja Marc, Ron H.N. van Schaik, Gerard Siest, Elvar Theodorsson, Chiara Di Resta A57 MCI or early dementia predictive speech based diagnosis techniques Matus Pleva, Jozef Juhar A58 Personalized speech based mobile application for eHealth Matus Pleva, Jozef Juhar A59 Circulating tumor cell-free DNA as the biomarker in the management of cancer patients Jiří Polívka jr., Filip Janků, Martin Pešta, Jan Doležal, Milena Králíčková, Jiří Polívka A60 Complex stroke care – educational programme in Stroke Centre University Hospital Plzen Jiří Polívka, Alena Lukešová, Nina Müllerová, Petr Ševčík, Vladimír Rohan A61 Sleep apnea and sleep fragmentation contribute to brain aging Kneginja Richter, Lence Miloseva, Günter Niklewski A62 Personalised approach for sleep disturbances in shift workers Kneginja Richter, Jens Acker, Guenter Niklewski A63 Medical travel and innovative PPPM clusters: new concept of integration Olga Safonicheva, Vincenzo Costigliola A64 Medical travel and women health Olga Safonicheva A65 Continuity of generations in the training of specialists in the field of reconstructive microsurgery Maxim Sautin, Janna Sinelnikova, Sergey Suchkov A66 Telemonitoring of stroke patients – empirical evidence of individual risk management results from an observational study in Germany Songül Secer, Stephan von Bandemer A67 Women’s increasing breast cancer risk with n-6 fatty acid intake explained by estrogen-fatty acid interactive effect on DNA damage: implications for gender-specific nutrition within personalized medicine Niva Shapira A68 Cytobacterioscopy of the gingival crevicular fluid as a method for preventive diagnosis of periodontal diseases Aleksandr Shcherbakov, Anatoly A. Kunin, Natalia S. Moiseeva A69 Use of specially treated composites in dentistry to avoid violations of aesthetics Bogdan R. Shumilovich, Zhanna Lipkind, Yulia Vorobieva, Dmitry A. Kunin, Anastasiia V. Sudareva A70 National eHealth system – platform for preventive, predictive and personalized diabetes care Ivica Smokovski, Tatjana Milenkovic A72 The common energy levels of Prof. Szent-Györgyi, the intrinsic chemistry of melanin, and the muscle physiopathology. Implications in the context of Preventive, Predictive, and Personalized Medicine Arturo Solís-Herrera, María del Carmen Arias-Esparza, Sergey Suchkov A73 Plurality and individuality of hepatocellular carcinoma: PPPM perspectives Krishna Chander Sridhar, Olga Golubnitschaja A74 Strategic aspects of higher medical education reforms to secure newer educational platforms for getting biopharma professionals matures Maria Studneva, Sihong Song, James Creeden, Мark Мandrik, Sergey Suchkov A75 Overview of the strategies and activities of the European Federation of Clinical Chemistry and Laboratory Medicine, (EFLM) Elvar Theodorsson, EFLM A76 New spectroscopic techniques for point of care label free diagnostics Syed A. M. Tofail A77 Tumor markers for personalized medicine and oncology - the role of Laboratory Medicine Ondřej Topolčan, Judita Kinkorová, Ondřej Fiala, Marie Karlíková, Šárka Svobodová, Radek Kučera, Radka Fuchsová, Vladislav Třeška, Václav Šimánek, Ladislav Pecen, Jan Šoupal, Štěpán Svačina2 A78 Modern medical terminology (MMT) as a driver of the global educational reforms Evgeniya Tretyak, Maria Studneva, Sergey Suchkov A79 Juvenile hypertension; the relevance of novel predictive, preventive and personalized assessment of its determinants Francesca M. Trovato, G. Fabio Martines, Daniela Brischetto, Daniela Catalano, Giuseppe Musumeci, Guglielmo M. Trovato A80 Proteomarkers Biotech George Th. Tsangaris, Athanasios K. Anagnostopoulos A81 Proteomics and mass spectrometry based non-invasive prenatal testing of fetal health and pregnancy complications George Th. Tsangaris, Athanasios K. Anagnostopoulos A82 Integrated Ecosystem for an Integrated Care model for Heart Failure (HF) patients including related comorbidities (ZENITH) José Verdú, German Gutiérrez, Jordi Rovira, Marta Martinez, Lutz Fleischhacker, Donna Green, Arthur Garson, Elena Tamburini, Stefano Cuomo, Juan Martinez-Leon, Teresa Abrisqueta, Hans-Peter Brunner-La Rocca, Tiny Jaarsma, Teresa Arredondo, Cecilia Vera, Giuseppe Fico, Olga Golubnitschaja, Fernando Arribas, Martina Onderco, Isabel Vara, on behalf of ZENITH consortium A83 Predictive, preventive and personalized medicine in diabetes onset and complication (MOSAIC project) José Verdú, Francesco Sambo, Barbara Di Camillo, Claudio Cobelli, Andrea Facchinetti, Giuseppe Fico, Riccardo Bellazzi, Lucia Sacchi, Arianna Dagliati, Daniele Segnani, Valentina Tibollo, Manuel Ottaviano, Rafael Gabriel, Leif Groop, Jacqueline Postma, Antonio Martinez, Liisa Hakaste, Tiinamaija Tuomi, Konstantia Zarkogianni, on behalf of MOSAIC consortium A84 Possibilities for personalized therapy of diabetes using in vitro screening of insulin and oral hypoglycemic agents Igor Volchek, Nina Pototskaya, Andrey Petrov A85 The innovative technology for personalized therapy of human diseases based on in vitro drug screening Igor Volchek, Nadezhda Pototskaya, Andrey Petrov A86 Bone destruction and temporomandibular joint: predictive markers, pathogenetic aspects and quality of life Ülle Voog-Oras, Oksana Jagur, Edvitar Leibur, Priit Niibo, Triin Jagomägi, Minh Son Nguyen, Chris Pruunsild, Dagmar Piikov, Mare Saag A87 Sub-optimal health management – global vision for concepts in medical travel Wei Wang A88 Sub-optimal health management: synergic PPPM-TCAM approach Wei Wang A89 Innovative technologies for minimal invasive diagnostics Andreas Weinhäusel, Walter Pulverer, Matthias Wielscher, Manuela Hofner, Christa Noehammer, Regina Soldo, Peter Hettegger, Istvan Gyurjan, Ronald Kulovics, Silvia Schönthaler, Gabriel Beikircher, Albert Kriegner, Stephan Pabinger, Klemens Vierlinger A90 Rare disease diobanks for personalized medicine Ayşe Yüzbaşıoğlu, Meral Özgüç, Member of EuroBioBank - European Network of DNA, Cell and Tissue Banks for Rare Disease

A study of clinical and pathological correlation in cases of thrombotic microangiopathy

Background : Thrombotic Microangiopathy (TMA) is defined as a lesion comprising vessel wall thickening (mainly arterioles and capillaries), intra luminal thrombosis and partial or complete obstruction of the vessel lumina.Thrombotic Microangiopathies are a group of conditions characterized by micro vascular thrombosis leading to thrombocytopenia, hemolytic anemia and red cell fragmentation.Objective : Retrospective analysis of clinical and pathological features of patients with thrombotic microangiopthy.Methods :Twenty eight patients who were diagnosed histopathologically as cases of thrombotic microangiopthy in Gandhi Hospital over a period of 5 years from August 2005 to July 2010 were included in this study. Renal profile including ultrasound study were carried out in all cases and repeated every month. Results: Of the total twenty eight patients 15 were males (54%), 13 were females (46%). Aetiology consists of diarrhea associated HUS (36%), idiopathic (18%), post transplant HUS (14%), post partum HUS (14%), malignant hypertension (11%) and SLE with APLA (7%) leading to thrombotic microangiopthy. Clinical presentations were oligoanuria in 89%, anasarca in 85%, hypertension in 85%, jaundice in 39%, diarrhea in 36%, bleeding diathesis in 25%, seizures in 18% and gross hematuria in 7%. Anemia and thrombocytopenia were universal features. Conclusion: This study shows glomerular changes were predominant in children with thrombotic microangiopthy. Adults with thrombotic microangiopthy have glomerular as well as vascular changes. An attempt has been made to study renal survival and Dialysis dependency in the patients studied by having follow up of one year

Discrimination between synthetically administered and endogenous thiouracil based on monitoring of urine, muscle, and thyroid tissue : an in vivo study in young and adult bovines

Thiouracil (TU), synthesized for its thyroid-regulating capacities and alternatively misused in livestock for its weight-gaining effects, is acknowledged to have an endogenous origin. Discrimination between low-level abuse and endogenous occurrence is challenging and unexplored in an experimental setting. Therefore, cows (n = 16) and calves (n = 18) were subjected to a rapeseed-supplemented diet or treated with synthetic Till. Significant higher urinary TU levels were recorded after TU administration (<CC alpha 15 642 mu g L-1) compared to rapeseed supplementation (<CC alpha, 5.8 mu g L-1), however, with overlapping values. TU was not detected in the edible meat; however, concentrations between the CC alpha, and 10 mu g kg(-1) were noted in thyroid tissue of calves and cows following rapeseed supplementation. The latter concentrations were significantly higher in thyroid tissue of calves (22.9-41.8 mu g kg(-1)) and cows (16.9-36.7 mu g kg (-1)) after synthetic TU administration. These results strongly point toward thyroid analysis as a discriminatory tool.

Estimation of Autoignition Propensity in Aeroderivative Gas Turbine Premixers Using Incompletely Stirred Reactor Network Modeling

Abstract The study of autoignition propensity in premixers for gas turbines is critical for their safe operation and design. Although premixers can be analyzed using reacting computational fluid dynamics (CFD) coupled with detailed autoignition chemical kinetics, it is essential to also develop methods with lower computational cost to be able to explore more geometries and operating conditions during the design process. This paper presents such an approach based on incompletely stirred reactor network (ISRN) modeling. This method uses a CFD solution of a nonreacting flow and subsequently estimates the spatial evolution of reacting scalars such as autoignition precursors and temperature conditioned on the mixture fraction, which is used to quantify autoignition propensity. The approach is intended as a “postprocessing” step, enabling the use of very complex chemical mechanisms and the study of many operating conditions. For a representative premixer of an aeroderivative gas turbine, results show that autoignition propensity can be reproduced with ISRN at highly reactive operating conditions featuring multi-stage autoignition of a dual fuel mixture. The ISRN computations are consequently analyzed to explore the evolution of reacting scalars and propose some autoignition metrics that combine mixing and chemical reaction to assist the design of premixers.Siemens Energ